NCT01481701View on ClinicalTrials.gov

A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Ovarian CarcinomaRelapse
Interventions
DRUG

Oxaliplatin

85 mg/m² / 14days

DRUG

oxaliplatin

oxaliplatin

Trial Locations (1)

1000

Institut Jules Bordet, Brussels

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER